Traphagen Investment Advisors LLC Purchases 243 Shares of Oracle Corporation $ORCL

Traphagen Investment Advisors LLC boosted its position in shares of Oracle Corporation (NYSE:ORCL) by 3.0% in the second quarter, Holdings Channel.com reports. The institutional investor owned 8,277 shares of the enterprise software provider’s stock after acquiring an additional 243 shares during the period. Traphagen Investment Advisors LLC’s holdings in Oracle were worth $1,810,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Reyes Financial Architecture Inc. grew its stake in Oracle by 7.2% during the 2nd quarter. Reyes Financial Architecture Inc. now owns 643 shares of the enterprise software provider’s stock worth $141,000 after buying an additional 43 shares during the last quarter. Creative Capital Management Investments LLC raised its stake in shares of Oracle by 5.7% in the second quarter. Creative Capital Management Investments LLC now owns 798 shares of the enterprise software provider’s stock worth $174,000 after purchasing an additional 43 shares during the last quarter. Davis Investment Partners LLC raised its position in Oracle by 0.7% during the second quarter. Davis Investment Partners LLC now owns 6,930 shares of the enterprise software provider’s stock valued at $1,517,000 after acquiring an additional 46 shares in the last quarter. Acropolis Investment Management LLC grew its holdings in Oracle by 2.6% in the second quarter. Acropolis Investment Management LLC now owns 1,850 shares of the enterprise software provider’s stock valued at $404,000 after purchasing an additional 47 shares during the period. Finally, Sunpointe LLC raised its holdings in shares of Oracle by 0.9% during the second quarter. Sunpointe LLC now owns 5,563 shares of the enterprise software provider’s stock valued at $1,216,000 after acquiring an additional 48 shares during the last quarter. 42.44% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, Director Naomi O. Seligman sold 2,222 shares of the firm’s stock in a transaction on Friday, September 26th. The stock was sold at an average price of $288.91, for a total transaction of $641,958.02. Following the sale, the director owned 29,225 shares in the company, valued at $8,443,394.75. This trade represents a 7.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Clayton M. Magouyrk sold 21,241 shares of the firm’s stock in a transaction on Friday, September 12th. The stock was sold at an average price of $297.11, for a total value of $6,310,913.51. Following the sale, the insider owned 78,000 shares in the company, valued at $23,174,580. This trade represents a 21.40% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 104,314 shares of company stock worth $31,272,223 over the last ninety days. Company insiders own 40.90% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on ORCL. BNP Paribas set a $377.00 price objective on Oracle in a research report on Wednesday, September 10th. Guggenheim boosted their price objective on Oracle from $250.00 to $375.00 and gave the company a “buy” rating in a report on Wednesday, September 10th. BMO Capital Markets set a $345.00 target price on Oracle in a research note on Wednesday, September 10th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $240.00 target price (up from $200.00) on shares of Oracle in a research note on Thursday, June 12th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Oracle in a research report on Saturday, September 27th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-five have given a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $304.71.

Oracle Stock Performance

Oracle stock opened at $284.46 on Wednesday. The company has a debt-to-equity ratio of 3.33, a quick ratio of 0.62 and a current ratio of 0.62. The stock has a fifty day moving average of $264.10 and a two-hundred day moving average of $207.36. The company has a market capitalization of $810.94 billion, a price-to-earnings ratio of 65.85, a PEG ratio of 3.14 and a beta of 1.53. Oracle Corporation has a fifty-two week low of $118.86 and a fifty-two week high of $345.72.

Oracle (NYSE:ORCL) last released its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing the consensus estimate of $1.48 by ($0.01). Oracle had a return on equity of 72.93% and a net margin of 21.08%.The company had revenue of $14.93 billion for the quarter, compared to analysts’ expectations of $15.04 billion. During the same period in the previous year, the business posted $1.39 EPS. The business’s quarterly revenue was up 12.2% on a year-over-year basis. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, analysts anticipate that Oracle Corporation will post 5 EPS for the current fiscal year.

Oracle Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be issued a dividend of $0.50 per share. The ex-dividend date is Thursday, October 9th. This represents a $2.00 annualized dividend and a dividend yield of 0.7%. Oracle’s dividend payout ratio (DPR) is 46.30%.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.